Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Casma Therapeutics is raising $46,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Keith Dionne played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Casma Therapeutics
Were harnessing the natural cellular process of autophagy to design powerful new medicines for a broad range of diseases.

To learn more about Casma Therapeutics, visit http://www.casmatx.com/

Contact:
Keith Dionne, Chief Executive Officer
857-777-4990

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved